For the first time, we demonstrate that pregnancy-level PRL directly enhances JAK2/STAT3 and JAG1/NOTCH1 signaling in CRC cells, promoting epithelial-mesenchymal transition (EMT) and cancer stem-like protein expression. The gene discussed is PRL; the disease is cancer.